Evidence map›Paper›PMID 29808465›Full record

ArticleNeurogenetics2018

A novel missense variant in the SDR domain of the WWOX gene leads to complete loss of WWOX protein with early-onset epileptic encephalopathy and severe developmental delay.

Jessika Johannsen, Fanny Kortüm, Georg Rosenberger, Kristin Bokelmann, Markus A Schirmer, Jonas Denecke, René Santer

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Neurogenetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Case report: Adult patient withFrontiers in genetics · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. WWOX and metabolic regulation in normal and pathological conditions.Journal of molecular medicine (Berlin, Germany) · 2022
    Review
  7. Frontiers in genetics · 2022
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. TheFrontiers in cellular neuroscience · 2019
    Article
  14. WWOX-associated encephalopathies: identification of the phenotypic spectrum and the resulting genotype-phenotype correlation.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2018
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jessika JohannsenDepartment of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. j.johannsen@uke.de.ORCID 0000-0002-2095-3891
Fanny KortümInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Georg RosenbergerInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kristin BokelmannInstitute of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany.
Markus A SchirmerClinic of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Göttingen, Germany.
Jonas DeneckeDepartment of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
René SanterDepartment of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Universität Hamburg · DEUniversitätsmedizin Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human WWOX (WW domain-containing oxidoreductase) gene, originally known as a tumor suppressor gene, has been shown to be important for brain function and development. In recent years, mutations in WWOX have been associated with a wide phenotypic spectrum of autosomal recessively inherited neurodevelopmental disorders. Whole exome sequencing was completed followed by Sanger sequencing to verify segregation of the identified variants. Functional WWOX analysis was performed in fibroblasts of one patient. Transcription and translation were assessed by quantitative real-time PCR and Western blotting. We report two related patients who presented with early epilepsy refractory to treatment, progressive microcephaly, profound developmental delay, and brain MRI abnormalities. Additionally, one of the patients showed bilateral optic atrophy. Whole exome sequencing revealed homozygosity for a novel missense variant affecting the evolutionary conserved amino acid Gln230 in the catalytic short-chain dehydrogenase/reductase (SDR) domain of WWOX in both girls. Functional studies showed normal levels of WWOX transcripts but absence of WWOX protein. To our knowledge, our patients are the first individuals presenting the more severe end of the phenotypic spectrum of WWOX deficiency, although they were only affected by a single missense variant of WWOX. This could be explained by the functional data indicating an impaired translation or premature degradation of the WWOX protein.

Indexed as

Mutation, MissenseAfghanistanAge of OnsetCells, CulturedChildConsanguinityDevelopmental DisabilitiesEpilepsyFamilyFemaleHEK293 CellsHumansInfant, NewbornPedigreeProtein DomainsRNA StabilityTumor Suppressor ProteinsWW Domain-Containing OxidoreductaseWWOX protein, humanEpileptic encephalopathyMissense variantProtein lossWWOX geneWWOX protein

Identifiers

PMID29808465
OpenAlexW2806313430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.